SCHEMBL30494348

SCHEMBL30494348

O=c1[nH]c2ccc(-c3cccnc3)cc2o1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 3/20 0.70
PDE3A Q14432 3/20 0.70
CYP19A1 P11511 2/20 0.58
PGR P06401 1/20 0.51
NOS1 P29475 1/20 0.49
PIM1 P11309 1/20 0.47
PIM2 Q9P1W9 1/20 0.47
FGFR1 P11362 1/20 0.47
OGT O15294 1/20 0.46
CYP11B1 P15538 7/20 0.46
CYP11B2 P19099 7/20 0.46
CYP1A2 P05177 3/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2A6 P11509 1/20 0.46
QPCT Q16769 1/20 0.46
QPCTL Q9NXS2 1/20 0.46
CDC7 O00311 1/20 0.45
CCNE1 P24864 1/20 0.45
CDK2 P24941 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1762375 1.00 PDE3B (0.70) PDE3BPDE3ACYP19A1PGRNOS1
SCHEMBL11251932 0.90 PDE3B (0.68) PDE3BPDE3ACYP19A1PGRNOS1
SCHEMBL1423560 0.83 NPC1 (0.58) PDE3BPDE3AALDH1A1
SCHEMBL26463815 0.83 PDE3B (0.56) PDE3BPDE3ACYP19A1PGRNOS1
SCHEMBL30494269 0.83 PDE3B (0.56) PDE3BPDE3ACYP19A1PGRNOS1
SCHEMBL17260655 0.82 PDE3B (0.71) PDE3BPDE3APGRNOS1OGT
SCHEMBL1884142 0.81 PDE3B (0.49) PDE3BPDE3ACYP19A1PGRNOS1
SCHEMBL26463620 0.79 PDE3B (0.62) PDE3BPDE3ANOS1PIM1PIM2
SCHEMBL30494176 0.79 PDE3B (0.62) PDE3BPDE3ANOS1PIM1PIM2
SCHEMBL1878615 0.78 KMO (0.55) PDE3BPDE3ACYP19A1NOS1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236613-A1 SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2025-07-24 US disclosed
EP-4423067-A1 SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-09-04 EP disclosed
CN-118176181-A SARM1 modulators, their preparation and use 维泰瑞隆有限公司 2024-06-11 CN disclosed
WO-2023072026-A1 SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250236613-A1 SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF SARM1, ADRM1, SMN1; SMN2 PDE3B 3476/4885PDE3A 3190/4885CYP19A1 4700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.